Combination treatment efficient for high astigmatism correction

Article

Combined toric lens implantation and astigmatic keratotomy is a safe and effective way to correct high astigmatism, according to findings published in Techniques in Ophthalmology.

Combined toric lens implantation and astigmatic keratotomy is a safe and effective way to correct high astigmatism, according to findings published in Techniques in Ophthalmology.

Dr Robert H. Osher et al., Cincinnati Eye Institute, Cincinnati, Ohio, USA, studied 20 eyes with keratometric astigmatism with a mean of 4.05 D. All patients were implanted with a toric IOL combined with astigmatic keratotomy. The outcome measure was uncorrected distance visual acuity (UDVA).

All patients attained a UDVA of 20/40 or better. Of the 20 eyes studied, 8 eyes achieved a UDVA of 20/25 or better and 16 eyes achieved 1 D or less of refractive cylinder. Additionally, no complications occurred either intra- or postoperatively and the full group indicated satisfaction with their visual results.

The results demonstrated that through combining toric IOL implantation and astigmatic keratotomy it is possible to reduce high astigmatism in cataract patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.